Job overview

Advertised whilst awaiting RCR approval

This is a new post is for 10 Programmed Activities (PAs) per week to provide Clinical Oncology management and treatment with in the HPB and Colorectal Disease Groups.

The Clinical Oncologist appointed will work with the HPB and Colorectal teams to provide a comprehensive clinical service for their patients. This includes patients in the outpatient, inpatient and ambulatory settings, delivering Radiotherapy and Systemic Anti-Cancer Therapy (SACT) whilst also providing Clinical Oncology input to the associated MDTs.

This post will demonstrate excellent and equitable clinical outcomes and patient safety, patient experience and clinical effectiveness for those patients living with and beyond cancer and will also support the existing teams with the increase in activity and the management of the waiting times for their disease groups.

All Disease Group consultants work as part of a multi-disciplinary team supporting the delivery of this work including Nurse Clinicians/Advanced Clinical Practitioners (including trainee’s) 8.65 WTE, Clinical Nurse Specialists 7.66 WTE, Clinical/research Fellows 1.8 WTE, Specialist Trainees 4.4 WTE along with access to a team of Pharmacists, Research Nurses and Specialist Radiographers 2 WTE.

Main duties of the job

Colorectal 

The appointee will be expected to develop a significant interest in colorectal oncology delivering radiotherapy & systemic therapy.
The post holder will be actively involved delivering all aspects of radiotherapy & encouraged to engage with teams supporting SABR, Proton or MR Linac development. Well supported team structure & ethos facilitates cross-cover of clinical work. Training/mentorship can be provided if required.
Post holder is expected to take on leadership, training & management roles as an active member of the Clinical Oncology. Examples include: being a Chair of a clinial committee, Clinical Lead of a clinical pathway or clinical representative at Trust meetings.

HPB

Appointee will provide consultant level care for patients with HPB malignancies (composed of pancreatic cancer, biliary tract cancers (cholangiocarcinoma and gallbladder cancer), hepatocellular carcinoma) & abdominal oligometastatic tumours. Including providing specialist expertise Radiotherapy (including MR guided Adaptive RT) & systemic therapy, Stereotactic Ablative Radiotherapy & other precision radiation treatment options for abdominal oligometastatic sites, outpatient care through the outpatient clinics and Linacs, where Systemic Anti-Cancer Therapy and Radiotherapy treatments are delivered, as well as inpatient care on the main adult oncology wards. 

Both area’s have very active research studies on going.

Working for our organisation

The Christie is one of Europe’s leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country.

We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years.

We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.